„First Line“
Suchergebnisse
3.416 Treffer
-
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
-
Correction to: Rapid Genomic and Genetic Changes in the First Generation of Autotetraploid Lineages Derived from Distant Hybridization of Carassius auratus Red Var. (♀) × Megalobrama amblycephala (♂)
-
Correction to: Osimertinib as first-line therapy in advanced NSCLC: a profile of its use
-
Correction to: Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
-
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial
-
Development and Validation of a Pathomics-Based Prognostic Model for Patients with Lung Adenocarcinoma Undergoing First-Line EGFR-TKI Therapy
-
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
-
Metric Linear-Time Temporal Logic with Strict First-Time Semantics
-
An Introduction to First-Order Linear Temporal Logic (Invited Talk)
-
Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
-
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
-
From guidelines to evidence-based practice – a German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis
-
Implementing prehospital invasive arterial blood pressure monitoring in critically ill patients-a prospective observational first year analysis
-
First-Line Treatment for Advanced Hepatocellular Carcinoma – A Three-Armed Real-World Comparison
-
Analysis of the clinical value and applicability of tumour regression grading systems for pancreatic ductal adenocarcinoma with FOLFIRINOX as first-line neoadjuvant therapy
-
Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer
-
Correction: Pan-intestinal capsule endoscopy as first-line procedure in patients with suspected mid or lower gastrointestinal bleeding
-
Global continuation for first order systems over the half‐line involving parameters
-
Optimizing bevacizumab dosing in first-line ovarian cancer treatment: the PGOG-ov1 trial
-
Impact of first-line dual immuno-oncology combination therapy versus immuno-oncology plus tyrosine kinase inhibitor on outcomes of second-line VEGFR-TKI in advanced RCC: a real-world multi-institutional analysis